The invention relates to amorphous solid dispersion of dapagliflozin and EUDRAGIT® and process for the preparation thereof. The invention also relates to pharmaceutical composition comprising amorphous solid dispersion of dapagliflozin and EUDRAGIT® together with one or more pharmaceutically acceptable excipients.